Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas

Lawrence A Donehower1, Thierry Soussi2, Anil Korkut3

  • 1Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.

Cell Reports
|August 1, 2019
PubMed

Insights

TP53 mutations are common in cancers and lead to genomic instability and altered gene expression. These changes in the TP53 pathway significantly impact tumor development and reduce patient survival across multiple cancer types.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • The TP53 tumor suppressor gene is frequently altered in human cancers.
  • Understanding the p53 pathway's role is crucial for cancer research.

Purpose of the Study:

  • To comprehensively assess p53 pathway involvement in 32 cancer types using TCGA data.
  • To investigate the genomic and expression consequences of TP53 mutations.

Main Methods:

  • Analysis of 10,225 patient samples across 32 cancer types from five data platforms.
  • Examination of TP53 mutation status, second allele loss, and chromosomal instability.
  • Assessment of RNA, miRNA, and protein expression patterns in tumors with and without TP53 mutations.

Main Results:

  • Over 91% of TP53-mutant cancers showed second allele loss.
  • TP53 mutations correlated with increased chromosomal instability, oncogene amplification, and tumor suppressor gene deletion.
  • Mutant TP53 tumors exhibited distinct expression profiles, including enhanced cell cycle gene and protein expression.
  • A mutant TP53 RNA expression signature was linked to reduced survival in 11 cancer types.

Conclusions:

  • TP53 mutations profoundly impact tumor cell genomic structure and expression.
  • TP53 mutation status is a significant factor in cancer development and clinical outcome.
  • Targeting the p53 pathway may offer therapeutic strategies for various cancers.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...